- 2.4Impact Factor
- 4.1CiteScore
- 18 daysTime to First Decision
Special Issues
Medicina publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Chronic Inflammatory Skin Diseases: Where We Are and Where We Are Going: 2nd Edition
Deadline: 30 September 2026
Advances in the Diagnosis and Treatment of Cutaneous Melanoma
Deadline: 30 September 2026
Invasive and Non-Invasive Dermatological Imaging: Dermatopathology, Dermoscopy, In Vivo High-Resolution Images, and Dermatoradiology
Deadline: 10 September 2026
Recent Advances in Diagnosis and Therapy of Inflammatory Skin Diseases
Deadline: 20 August 2026
Dermato-Engineering and AI Assessment in Dermatology Practice
Deadline: 28 July 2026
Alopecia: Latest Advances and Prospects
Deadline: 1 July 2026
Emerging Trends in Immunodermatology and Autoimmune Skin Disorders
Deadline: 31 March 2026
Cutaneous Melanoma: Updating from Pathogenesis to Therapy
Deadline: 28 February 2026
Psoriasis and Related Conditions: Recent Advances and Controversies
Deadline: 31 December 2025
Melanoma: Updates and Path Forward
Deadline: 31 December 2025
Tissue-Guided Repair
Deadline: 31 December 2025
Inflammatory Skin Diseases and Comorbidities
Deadline: 30 September 2024
of 2

